Advertisement

Topics

Search Results for "Latest Mesh Litigation News"

12:23 EST 21st January 2017 | BioPortfolio

Matching Channels

Facebook - BioPortfolio Pages

BioPortfolio has launched a number of Facebook pages to allow our visitors to keep track with latest news, published paper and clinical trials by lead biotechnology and healthcare topics:- &nbs...

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

Siemens

Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...

Clinical Trials Phase News

Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will norma...

Antibody classes

An antibody, also known as an immunoglobulin, is a large Y-shaped protein used by the immune system to identify and neutralize foreign objects such as bacteria and viruses. The antibody recognizes a...

Matching News

Study finds mixed results for use of mesh for hernia repair

Among patients undergoing incisional hernia repair, the use of mesh to reinforce the repair was associated with a lower risk of hernia recurrence over 5 years compared with when mesh was not used, alt...

Complications arise from mesh used in pelvic surgeries

A synthetic mesh commonly used to treat a form of urinary incontinence as well as the weakening of the female pelvis's walls can lead to complications that increase in frequency with the amount of mes...

Mesh Benefits Partly Offset by Complications at 5 Years

New data on the use of mesh in patients undergoing hernia repair prompt nuanced discussion about the benefit and risk calculation, with emphasis on the need for long-term postsurgical follow-up. Med...

[Articles] Adverse events after first, single, mesh and non-mesh surgical procedures for stress urinary incontinence and pelvic organ prolapse in Scotland, 1997–2016: a population-based cohort study

Our results support the use of mesh procedures for incontinence, although further research on longer term outcomes would be beneficial. Mesh procedures for anterior and posterior compartment prolapse ...

Mesh vs. Suture Closure of Incisional Hernias

Recurrences are less common, but long-term complications are more common, with mesh repair.

[Articles] Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT)

Augmentation of a vaginal repair with mesh or graft material did not improve women's outcomes in terms of effectiveness, quality of life, adverse effects, or any other outcome in the short term, but m...

Noted Litigator to Address American Urogynecologic Society Conference

HOUSTON, Sept. 26, 2016 /PRNewswire/ -- Derek H. Potts, founder and national managing partner of Potts Law Firm, will present on the current status of vaginal mesh sling litigation at the prestigious ...

More Vaginal Mesh Tied to More Postoperative Complications

There may be a dose-response relationship between the amount of mesh used to correct pelvic organ prolapse and stress urinary incontinence and subsequent complications and repeated interventions, rese...

Matching PubMed Articles

Analysis of Surgical Outcomes and Determinants of Litigation Among Women With Transvaginal Mesh Complications.

To identify litigation predictors among women with complications of transvaginal mesh.

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement